136.60SEK+0.89%Mkt Cap: 311.65M $P/E: 24.311d ago
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hemat…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap311.65M $
Enterprise Value291.77M $
Revenue (TTM)69.88M $
Gross Profit49.73M $
Net Income (TTM)14.64M $
Revenue/Share2.930 USD
Last Price136.60 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees241
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)24.31
P/E (Forward)16.62
PEG—
EV/EBITDA15.71
EV/Revenue4.18
P/S4.46
P/B3.56
EPS (TTM)5.62
EPS (Forward)8.22
52W Range
117.6025% of range192.20
52W High192.20 SEK
52W Low117.60 SEK
Profitability
Gross Margin68.50%
Oper. Margin17.12%
EBITDA Margin26.57%
Profit Margin20.17%
ROE17.25%
ROA13.98%
Growth
Revenue Growth-14.60%
Earnings Growth-45.80%
Cash Flow & Leverage
Operating CF19.18M $
CapEx (TTM)8.25M $
FCF Margin12.31%
FCF Yield2.76%
Net Debt-19.88M $
Net Debt/EBITDA-1.07
Balance Sheet
Debt/Equity0.03
Current Ratio3.80
Quick Ratio2.82
Book Value/Sh38.33 SEK
Cash/Share9.652 SEK
Dividends
Fwd Div Rate2.750 SEK
Trail. Div Rate2.750 SEK
Div. Yield2.03%
5Y Avg Yield1.02%
Payout Ratio44.48%
Ex-Div DateApr 29, 2026
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)171.25 SEK
Upside (mean)+25.4%
Target Range150.00 SEK – 180.00 SEK
SEK150.00+25.4% to meanSEK180.00
# Analysts4
Ownership
Shares Out.23.85M
Float19.50M
Insiders16.92%
Institutions72.01%
Technical
SMA 50130.26 (+4.9%)
SMA 200149.67 (-8.7%)
Beta0.96
S&P 52W Chg19.63%
Avg Vol (30d)53.52K
Avg Vol (10d)24.77K
Technical Indicators
RSI (14)51.3
MACD1.0625
MACD Signal1.7963
MACD Hist.-0.7337
BB Upper144.60 SEK
BB Middle137.81 SEK
BB Lower131.02 SEK
BB Width9.86%
ATR (14)5.023 SEK
Vol Ratio (20d)0.35x